These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8184623)

  • 41. [Effect of Opisthorchis infestation on the clinical course of typhoid fever and its outcome and on the indices of nonspecific and specific resistance. I. The effect of Opisthorchis infestation on the clinical course of typhoid fever and its outcome].
    Lepekhin AV
    Med Parazitol (Mosk); 1987; (5):21-4. PubMed ID: 3437833
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of typhus bacteria carriers].
    Münnich D
    Med Klin; 1970 Aug; 65(34):1486-90. PubMed ID: 5521072
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparative trial of amoxycillin and chloramphenicol in treatment of typhoid fever in adults.
    Pillay N; Adams EB; North-Coombes D
    Lancet; 1975 Aug; 2(7930):333-4. PubMed ID: 51141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A comprehensive evaluation of the biological properties of the causative agents of typhoid fever isolated from patients and carriers].
    Kolpakov SL; Semenova TF; Vostrova EI; Kashanova NI; Golovenko GI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):23-7. PubMed ID: 2251886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [TREATMENT OF TYPHOID CARRIERS WITH "AMPICILLIN"].
    MUENNICH D; VALU G; URI J
    Orv Hetil; 1964 Feb; 105():205-8. PubMed ID: 14139718
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prospects for treating chronic carriers of typhoid fever].
    Bilibin AF; Pogorel'skaia LV; Markova EA; Gogol' LG; Teleshevskaia EA
    Sov Med; 1972 May; 35(5):24-7. PubMed ID: 5042682
    [No Abstract]   [Full Text] [Related]  

  • 47. Investigation of the role of Vi antibodies and antibodies of IgA type in the low specific bactericidal activity of the serum in typhoid carriers.
    Karolcek J; Draskovicová M; Ciznár I
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):247-51. PubMed ID: 1179883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of lipopolysaccharides of Salmonella typhi isolated from carriers and patients suffering from typhoid fever.
    Strýĉková T; Farbakyová G
    Folia Microbiol (Praha); 1976; 21(1):21-7. PubMed ID: 2523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapeutic results using combined antibiotic therapy in chronic carriers].
    Horn M; Tauchnitz C; Förster E; Kirsch WD; Weiss C
    Z Gesamte Inn Med; 1977 Aug; 32(15):Suppl: 238-9. PubMed ID: 919651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vi serology in detection of chronic Salmonella typhi carriers in an endemic area.
    Lanata CF; Levine MM; Ristori C; Black RE; Jimenez L; Salcedo M; Garcia J; Sotomayor V
    Lancet; 1983 Aug; 2(8347):441-3. PubMed ID: 6192305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of multi-drug resistant Salmonella typhi among clinically diagnosed typhoid fever patients in Lagos, Nigeria.
    Akinyemi KO; Coker AO; Olukoya DK; Oyefolu AO; Amorighoye EP; Omonigbehin EO
    Z Naturforsch C J Biosci; 2000; 55(5-6):489-93. PubMed ID: 10928566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of typhoid and paratyphoid excretors with sulprim].
    Becker H; Hesse P; Anger G
    Z Arztl Fortbild (Jena); 1982 Nov; 76(22):965-6. PubMed ID: 6820588
    [No Abstract]   [Full Text] [Related]  

  • 53. Editorial: Treatment of typhoid fever and typhoid carriers in Southeast Asia: --Viewpoint from Thailand.
    Lexomboon U; Mansuwan P
    Drugs; 1975; 9(4):243-5. PubMed ID: 1126308
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pathogenetic and immunological characteristics of different forms of the Salmonella typhi carrier state].
    Obgol'ts AA; Kononov AV; Konev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):71-6. PubMed ID: 3604512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effectiveness of cefotaxime and other antibiotics to the typhoid and paratyphoid B carriers with gall stones and typhoid fever (author's transl)].
    Kurimura O; Tamaki K; Sasaki H; Kobayashi S; Nozaki K; Morioka Y; Doi H
    Kansenshogaku Zasshi; 1980 Mar; 54(3):109-16. PubMed ID: 6247402
    [No Abstract]   [Full Text] [Related]  

  • 56. AMPICILLIN IN TREATMENT OF SALMONELLA TYPHI CARRIERS.
    WHITBY JM
    Lancet; 1964 Jul; 2(7350):71-2. PubMed ID: 14158684
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical evaluation of the leukergic reaction in infectious diseases complicated by adverse drug reactions].
    Gudimenko VI; Gracheva NM
    Sov Med; 1973 Apr; 36(4):90-4. PubMed ID: 4770014
    [No Abstract]   [Full Text] [Related]  

  • 58. Salmonella typhi carrier state 52 years after illness with typhoid fever: a case study.
    Shpargel JS; Berardi RS; Lenz D
    Am J Infect Control; 1985 Jun; 13(3):122-3. PubMed ID: 3849271
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of carriers of typhoid and paratyphoid B bacilli].
    Kassur B; Kociszewski J
    Przegl Epidemiol; 1975; 29(3):301-7. PubMed ID: 809812
    [No Abstract]   [Full Text] [Related]  

  • 60. Culture of Salmonella typhi and Salmonella paratyphi from blood and bone marrow in suspected typhoid fever.
    Gasem MH; Dolmans WM; Isbandrio BB; Wahyono H; Keuter M; Djokomoeljanto R
    Trop Geogr Med; 1995; 47(4):164-7. PubMed ID: 8560588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.